ERBB2 and neoplasm: Importantly, our analyses show that higher ERBB4 levels correlate with longer relapse-free survival only in luminal A and HER2+ subtypes, suggesting that the potential tumor-suppressive role of ERBB4 is restricted to these subtypes.